Articles from Biotech Business (July 1, 2005)

Title	Author	Type	Words
ALNYLAM INITIATES RNAI THERAPEUTIC PROGRAM FOR PANDEMIC FLU.			833
GENVEC GETS FDA CLEARANCE TO RESUME PHASE II TNFERADE TRIAL.			249
MARC GETS U.S. PATENT FOR BETULINOL DERIVATIVES FOR CANCER.			236
THRESHOLD GETS POSITIVE RESULTS FROM TH-070 PHASE 2 BPH TRIAL.			809
ZIOPHARM INITIATES 2ND PHASE I STUDY OF ZIO-101.			623